Thu, August 11, 2022
Wed, August 10, 2022
Tue, August 9, 2022
Mon, August 8, 2022

Gena Wang Maintained (BEAM) at Hold with Increased Target to $60 on, Aug 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-60-on-aug-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gena Wang of Barclays, Maintained "Beam Therapeutics Inc." (BEAM) at Hold with Increased Target from $38 to $60 on, Aug 10th, 2022.

Gena has made no other calls on BEAM in the last 4 months.



There are 2 other peers that have a rating on BEAM. Out of the 2 peers that are also analyzing BEAM, all agree with Gena's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $41 on, Friday, June 17th, 2022
  • Richard Law of "Credit Suisse" Initiated at Hold and Held Target at $62 on, Thursday, April 28th, 2022

Publication Contributing Sources